Alendronic Acid, Federal Supreme Court (Bundesgericht), 4 March 2011
November 2, 2011
Patentability of an invention is not excluded by the mere fact that the only feature of the patent claim not comprised in the state of the art is a dosage regime.
Click here for the full text of this case.
A full summary of this case has been published on Kluwer IP Law.
Comments (0)
Your email address will not be published.
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community!
Contact Editorial Guidelines
